 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 2711 | 回復(fù): 4 | |||||||
| 當前只顯示滿足指定條件的回帖，點擊這里查看本話題的所有回帖 | |||||||
[交流]
諾華上海研發(fā)中心招聘
|
|||||||
China Novartis Institutes for BioMedical Research Co., Ltd. (CNIBR) has some job vacancies as below. If you have interested in these jobs, please send your resume with no hesitation cause we'll provide you more chance to promote yourself in your field. Research Scientist-Liver Disease For more details, please click our career website: http://careers.novartis.com.cn/vacancies.html To apply this position, please send your resume to sarah.qi@novartis.com When you send your resume to sarah.qi@novartis.com, please notice you know this position information via 小木蟲BBS 諾華（中國）生物醫(yī)學(xué)研究有限公司是諾華全球研發(fā)組織――諾華生物醫(yī)學(xué)研究所（NIBR）的第八個研究基地。我們位于中國上海市張江高科技園區(qū)，將成為諾華在亞洲的主要研究中心，以及除在歐美的研究中心外的最主要的研究中心。我們的研究和探索開發(fā)活動的重點是發(fā)現(xiàn)并開發(fā)創(chuàng)新療法，用于治療在亞洲遠未達到醫(yī)藥需求的疾病。我們與從不同之處在于將專注現(xiàn)代藥物的發(fā)現(xiàn)和開發(fā)方法的研究。最初階段，研發(fā)工作將專注在引起中國地方性癌癥的感染原因。我們還將開展臨床試驗，進行安全性研究，生物標志物和檢測分析，表達譜、生物分析以及轉(zhuǎn)化醫(yī)學(xué)的研究。 隨著公司業(yè)務(wù)的迅速擴展，我們熱忱歡迎您的加入。同時我們將提供具有競爭力的薪酬福利待遇以及良好的培訓(xùn)發(fā)展機會。 NIBR Shanghai NIBR Shanghai is an integrated research center that is part of the Novartis global research and development network. The establishment of this strategic site is a commitment by Novartis to conduct cutting-edge pharmaceutical research in China. Research activities at NIBR Shanghai focus on addressing urgent medical needs in China, particularly infectious causes of cancer endemic to the region. The center also established programs in epigenetics, biomarker development, drug metabolism and preclinical safety to support NIBR local and global R&D projects.Research at NIBR Shanghai is currently focused on discovering new therapies for infectious causes of cancer, such as liver cancer caused by HBV or HCV hepatitis. As the diseases are highly prevalent in the region, some one-third of the 400 million people infected with the hepatitis B virus are in China, with estimates that 300,000 people die from liver cancer in the mainland each year. A Growing and Dynamic Organization China Novartis Institutes for BioMedical Research Co., Ltd. (CNIBR), the legal entity for NIBR Research Center in Shanghai was launched in November 2006 and the start-up Research facilities opened in April 2007. Today, NIBR Shanghai has grown to an organization of about 260 associates including nearly 200 scientists. The research teams are comprised of both returnee scientists from abroad (about 20% of total scientists), and graduates from top tier universities, medical centers, and research institutes in China. Currently the center operates in an office building and two lab facilities in the Zhangjiang Hi-Tech Park. In the same area, the new Novartis Shanghai Campus is under design and construction. The first phase of the project will be completed by the end of 2014. |
回復(fù)此樓» 猜你喜歡
求調(diào)劑，一志愿 南京航空航天大學(xué) ，080500材料科學(xué)與工程學(xué)碩，總分289分
已經(jīng)有9人回復(fù)
-
材料科學(xué)與工程求調(diào)劑
已經(jīng)有8人回復(fù)
-
一志愿大連理工大學(xué)材料求調(diào)劑
已經(jīng)有3人回復(fù)
-
一志愿北化085600材料專碩275|有文章專利｜求調(diào)劑
已經(jīng)有9人回復(fù)
-
材料求調(diào)劑 一志愿哈工大總分298分，前三科223分
已經(jīng)有8人回復(fù)
-
274求調(diào)劑
已經(jīng)有3人回復(fù)
-
合肥區(qū)域性重點一本招收調(diào)劑
已經(jīng)有4人回復(fù)
-
085600材料與化工調(diào)劑
已經(jīng)有10人回復(fù)
-
22408 359分調(diào)劑
已經(jīng)有7人回復(fù)
-
抱歉
已經(jīng)有4人回復(fù)
5樓2013-10-12 10:17:15
|
Research Scientist-Liver Disease Job Description China Novartis Institutes for Biomedical Research Co. Ltd (CNIBR) is currently seeking to fill a research scientist position in Biology Department. Self-motivated scientist with strong interest in drug discovery studies in liver diseases, esp in liver fibrosis/cirrhosis is welcome. The candidate will apply cell biology, molecular biology and biochemistry expertise on drug target validation, assay development, novel target identification as well as mechanistic studies. The candidate is expected to have the ability to handle multiple projects simultaneously and works in a fast-paced environment. Oral and written reports in English are also required regularly. Minimum requirements Candidates should hold an M.S./Ph.D. in Cell Biology, Molecular Biology, Developmental Biology or related field and have at least two years of relevant experience. Strong background and hands-on experience in liver diseases is preferred. The successful candidate is expected to have strong work ethic, excellent oral and written communication in English, and ability to function in an interdisciplinary team setting are essential. |
2樓2013-10-10 17:14:14
3樓2013-10-10 22:21:13
4樓2013-10-12 10:07:03
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿中海洋材料357 +3 | 麥恩莉. 2026-03-30 | 3/150 |
|
|---|---|---|---|---|
|
|
[考研] 調(diào)劑 +4 | GK72 2026-03-30 | 4/200 |
|
|
|
[考研] 085600 材料與化工 329分求調(diào)劑 +18 | Mr. Z 2026-03-25 | 19/950 |
|
|
[考研] 287求調(diào)劑 +14 | land xuxu 2026-03-26 | 14/700 |
|
|
|
[考研] 328求調(diào)劑 +8 | 嗯滴的基本都 2026-03-27 | 8/400 |
|
|
|
[考研] 375求調(diào)劑 +6 | 雨夏整夜 2026-03-29 | 6/300 |
|
|
|
[考研] 一志愿北京工業(yè)大學(xué)，324分求調(diào)劑 +6 | 零八# 2026-03-28 | 6/300 |
|
|
|
[考研] 調(diào)劑310 +12 | 溫柔的晚安 2026-03-25 | 13/650 |
|
|
|
[考研] 總分293求調(diào)劑 +8 | 加一一九 2026-03-25 | 11/550 |
|
|
|
[考研] 考研調(diào)劑 +7 | 小蠟新筆 2026-03-29 | 7/350 |
|
|
|
[考研] 352分-085602-一志愿985 +5 | 海納百川Ly 2026-03-29 | 5/250 |
|
|
|
[考研] 071000生物學(xué)求調(diào)劑，初試成績343 +7 | 小小甜面團 2026-03-25 | 7/350 |
|
|
|
[考研] 085602 化工專碩 338分 求調(diào)劑 +12 | 路癡小琪 2026-03-27 | 12/600 |
|
|
|
[考研] 085405 考的11408求各位老師帶走 +3 | Qiu學(xué)ing 2026-03-28 | 3/150 |
|
|
|
[考研] 285求調(diào)劑 +4 | AZMK 2026-03-27 | 7/350 |
|
|
|
[考研] 0703化學(xué)338求調(diào)劑！ +6 | Zuhui0306 2026-03-26 | 7/350 |
|
|
|
[考研] 求調(diào)劑 一志愿 本科 北科大 化學(xué) 343 +6 | 13831862839 2026-03-24 | 7/350 |
|
|
|
[考研] 一志愿哈工大，085400，320，求調(diào)劑 +4 | gdlf9999 2026-03-24 | 4/200 |
|
|
|
[考研] 296求調(diào)劑 +4 | 汪��？！ 2026-03-25 | 7/350 |
|
|
|
[考研]
 材料考研調(diào)劑生
+3
|
黃粱一夢千年 2026-03-24 | 3/150 |
|